Clinical trial
A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on…
NCT00134147 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00134147 |
|---|---|
| Title | A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control |
| Official title | A One Year, Open-Label Outpatient, Parallel Group Trial Assessing the Impact of the Availability of Inhaled Insulin (Exubera) on Glycemic Control in Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled on a Minimum of Two Oral Anti Diabetic Agents |
| Lead sponsor | Pfizer, Industry |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Inhaled Insulin |
| Enrollment | 1,100 |
| Start date | Apr 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Aug 24, 2005 |
| Last update posted | Apr 17, 2008 |
| Countries | Canada, France, Germany, Italy, Spain, United Kingdom, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: